Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral Sclerosis

NCT04454840 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

BIOLOGICAL: Plasma from healthy young people treatment + Riluzole
DRUG: Riluzole

Sponsor

Peking University Third Hospital